KROS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Keros Therapeutics Inc (KROS) does not present a strong buying opportunity for a beginner investor with a long-term strategy at this time. The technical indicators are mixed, with bearish moving averages and a neutral RSI. Options data suggests bearish sentiment with a high Open Interest Put-Call Ratio of 3.61. Additionally, there are no positive news catalysts, no significant insider or hedge fund activity, and no recent congress trading data. Given the lack of strong positive signals and the potential for short-term price declines, it is better to hold off on investing in KROS for now.
The MACD histogram is positive and expanding, indicating bullish momentum. However, the RSI is neutral at 63.108, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key resistance levels are at 10.734 and 11.024, while support levels are at 9.794 and 9.504. Overall, the technical outlook is mixed with a bearish bias.
NULL identified. No recent news, insider activity, or hedge fund activity. No congress trading data available.
Stock trend analysis indicates a 60% chance of price declines in the short term (-1.21% in the next day, -2.49% in the next week, -3.07% in the next month).
No financial data available for analysis.
No analyst rating or price target changes available for KROS.
